Systemic inflammation is central to aging-related conditions. However, the intrinsic factors that induce inflammation are not well understood. We previously identified a cell-autonomous pathway through which damaged nuclear DNA is trafficked to the cytosol where it activates innate cytosolic DNA sensors that trigger inflammation. These results led us to hypothesize that DNA released after cumulative damage contributes to persistent inflammation in aging cells through a similar mechanism. Consistent with this notion, we found that older cells harbored higher rescued from these phenotypes, supporting a role for extranuclear DNA in senescence. We hypothesize a direct role for excess DNA in aging-related inflammation and in replicative senescence, and propose DNA degradation as a therapeutic approach to remove intrinsic DNA and revert inflammation associated with aging.
heightened inflammation is observed in aging tissues, and in the blood of older adults in large epidemiologic studies, with consistently higher basal levels of C-reactive protein and abundant proinflammatory cytokines like IL-6, IFN-β, and TNF-α (Fagiolo et al., 1993; Roubenoff et al., 2003; Singh & Newman, 2011) . Such alteration is often viewed as noncell autonomous, for example senescent cells, which increase with aging, may modulate inflammation through secretion of cytokines (i.e., senescence-associated secretory phenotype, SASP ). The intrinsic processes that initiate this inflammation in aging remain largely unknown.
We previously described a cell-autonomous process in which damaged nuclear DNA is trafficked to the cytosol, transported via autophagy, and degraded by lysosomal nuclease DNASE2A. Excess DNA accumulated under conditions of increased damage, defective degradation, or autophagy blockade can activate the STING pathway leading to inflammation (Lan, Londono, Bouley, Rooney, & Hacohen, 2014) . DNA damage has been postulated to be a major cause of cellular aging. We hypothesize that cumulative damage may generate excess DNA leading to persistent inflammation in aging cells through a similar mechanism. Several observations in senescence seem to agree with our prediction. Unrepaired or persistent double-stranded breaks (DSBs) can be found in senescing cells and aging human and animal tissues (Rube et al., 2011; Sedelnikova et al., 2004; Wang et al., 2009) , and cells are known to senesce upon DNA damage (Le et al., 2010) . Senescent nuclei also undergo dramatic chromatin changes with fragments budding off the nucleus and being processed into autophagic vesicles (Ivanov et al., 2013) . Senescence and aging phenotypes in mice rely on type I IFN signaling (Yu et al., 2015) , which is one key response upon STING activation. Recent studies then reveal the involvement of DNA sensors in the induction of senescence (Glück et al., 2017; Yang, Wang, Ren, Chen, & Chen, 2017) , and nuclear DNA as the stimulatory ligand for nonautonomous SASP (Dou et al., 2017) .
Here, we test our original model in the context of aging, observing how nuclear DNA connects the intrinsic processes of damage, autophagy, sensing, degradation, and the induction of innate immune responses.
We used cellular replicative senescence as a model of aging and analyzed effects of extranuclear DNA on inflammation and senescence. In young and old human diploid fibroblasts (based on their replication age/population doubling, PD), we compared their levels of extranuclear DNA, transcriptional profiles, and sensing of intrinsic DNA in modulating innate immune responses. We then extended our study to clinical conditions of premature aging syndromes. We further tested a therapeutic approach of removing autonomous DNA to reduce inflammation in old cells. Finally, using mice deficient in DNASE2A, we observed a role for autonomous DNA and the STING pathway in promoting senescence. Altogether, we demonstrate that excess DNA contributes to inflammation and senescence, and reveal components of the DNA sensing and degradation machinery that could be targeted for modulation of aging-related innate immune responses.
| RESULTS

| Older cells accumulate DNA outside the nucleus
Based on prior studies showing increased DNA damage in older cells and our findings that excess damaged nuclear DNA leads to elevated cytosolic DNA, we hypothesized that cytosolic DNA would be more abundant in old compared to young cells. Using anti-double-stranded DNA (dsDNA) antibodies to detect DNA by immunofluorescence (IF), we found that 16.8% of old WI38 cells (human lung fibroblasts at PD68-70, approaching senescence) exhibited extranuclear DNA, in contrast to 2.6% in young cells (PD25-30), and DNA in the cytosol of old cells at much higher intensity than in young cells (Figure 1a) . These observations were confirmed in another fibroblast line, MRC5 (Figure 1c, untreated) . DNase1 digestion after fixation and permeabilization removed most of the cytosolic signals in old cells ( Figure S1A ), thus verifying that the signal in the cytosol was due to DNA as we showed previously (Lan et al., 2014) .
To confirm the presence of damaged DNA, we used TUNEL staining to label DNA nicks. Nicked DNA was strongly visible in old cells, prominently in the cytosol, but undetectable in young cells (Figure 1b, untreated) , and was more intense in old cells upon induction of DNA damage by the DNA damaging agent cytarabine/Ara-C which causes DSBs (Figure 1b , Ara-C-treated). Ara-C treatment also led to more extranuclear DNA in young cells (mostly speckles) and more nuclear DNA in old cells (Figure 1c ), suggesting there may be a saturation of DNA export to the cytosol.
| Nuclear origin and export of damaged DNA in aging cells
Excess mitochondrial DNA or mitochondria are not likely to be a source of the excess DNA in old cells since MitoTracker did not colocalize with excess DNA (Figure S1B ), though we do not exclude escape of DNA from mitochondria. However, blocking of nuclear transport to the cytosol with leptomycin B (LMB) led to a dramatic reduction in cytosolic DNA in old cells (Figure 1d ), along with some increase in dsDNA staining in nuclei of LMB-treated cells (likely due to blockage of export). Dual staining of dsDNA and a nuclear envelope marker NUP98 (nucleoporin 98) revealed patterns of nuclear DNA egress in old cells in the form of buds at the nuclear perimeter and speckles and large aggregates in the cytosol (which are patterns observed in our prior study) (Figure 1e ). Distribution of NUP98 was uneven or disrupted and nuclear lobulations could be severe (Figure 1e, right panel) . Both results support the nuclear origin of extranuclear DNA in these (likely nonphagocytic) fibroblasts.
In our model, autophagy is required for clearance of damaged nuclear DNA. We found an increased expression of autophagy genes in old cells compared with young cells, including ATG5, BECLIN1, and transcription regulators P62 and PTEN ( Figure S1C ), and the protein products of autophagosome marker LC3 and lysosomal protein LAMP1 ( Figure S1D ). Indeed, extranuclear DNA co-localized with 
| Innate immune expression profiles in old cells
| Cytosolic DNA accumulates and inflammatory pathways are activated in cells from premature aging syndromes
We wondered if our hypothesis that cytosolic DNA is a cell-intrinsic inflammatory ligand might extend to cells from humans with aging diseases. We focused on two genetic disorders, ataxia telangiectasia (AT), a severe neurodegenerative syndrome caused by gene defects in ATM (ataxia telangiectasia mutated) which is essential for DSB repair, and Hutchinson-Gilford progeria (HGPS or PS), which exhibits premature aging symptoms due to a mutation in LAMIN A (LMNA) that maintains nuclear architecture. Mutations of either disease gene, we reasoned, could lead to excess cytosolic DNA as a result of increased DNA damage (in AT) or leaky nuclear envelope (in PS). As hypothesized, we found prominent extranuclear dsDNA accumulation in the form of nuclear buds, speckles, and large fragments by anti-dsDNA IF staining in different AT and PS skin fibroblasts of patients but not healthy donors (Figure 3a ). DNA accumulation in both conditions also correlated with increased DSBs marked by γ-H2AX ( Figure S3A ). We then examined the innate immune profiles of the healthy and disease fibroblasts (H1, 4, 5; AT1-3; PS1-5) by RNA-seq. GSEA showed AT having 5 of 11 enriched gene sets in immune processes, including IFN-α, TNF-α, and IL-6 responses, while PS showed increased IL-6 signaling as the top enriched gene set ( Figure 3b ). By RT-qPCR, we observed higher expression of TNF-α, an important cytokine in inflammaging (Fagiolo et al., 1993; Roubenoff et al., 2003) 
| DNA burden impacts age-related inflammation
On a per cell basis, lysates from old cells showed a stronger capacity to degrade dsDNA than young cells, reflecting an elevated clearance of excess DNA by lysosomal DNASE2A (Figure 4a ). We reasoned that increased DNA degradation might restore the younger cell phenotype or even revert the process of senescence. As expected, (Figure 5a ), and slower growth by cell count (Figure 5b ) or the proliferation marker Ki67 ( Figure S5A ). SASP factors were upregulated in Dnase2a
MLFs ( Figure S5B ) and tissues, including kidney and heart (Figure S5C ), compared to Dnase2a +/+ mice as assessed by RT-qPCR.
Dnase2a
−/− cells also showed a higher percentage of cells with SA-β-gal activity in baseline or in response to Ara-C treatment, compared to Dnase2a +/+ cells (Figure 5c )-resembling the phenotype seen in response to DNA damage in old human cells ( Figure S1F ). In various tissues, such as kidney, liver, and brain, SA-β-gal activity was stronger in Dnase2a −/− than Dnase2a +/+ mice (Figure 5d ). Increased SA-β-gal activity also correlated with higher protein expression of the aging markers heterochromatin protein 1β (HP1β) and p16 in the kidney of Dnase2a −/− mice (Figure 5e ), though concomitant increase in p53 failed to elevate p21 expression ( Figure S5D ), suggesting additional regulation of this downstream effector. Higher p16 levels were similarly observed in less actively renewed tissues of brain and heart in Dnase2a −/− mice by immunohistochemical staining (Figure S5E) . We examined the requirement for DNA sensing using Dna- 
| DISCUSSION
In this study, we address the hypothesis that sensing and degradation of self-DNA impact inflammation in cells undergoing replicative senescence or cells derived from aging diseases. First, in late passage cells, we observed DNA exported from the nucleus through a leptomycin B-sensitive pathway and showed that inflammatory cytokines were induced through the STING pathway. Second, we found that inflammation could be reduced by overexpression of DNASE2A.
Finally, using a mouse model, we found that excess DNA burden led found to activate the STING pathway (Hartlova et al., 2015) . However, much more work is needed to understand the sources of excess DNA and damaged DNA in aging-related conditions.
A second question is how DNA is exported from the nucleus and appears in the cytosol to be detected by DNA sensors. Weakened or altered nuclear envelope in old cells can facilitate such an escape.
Deteriorated nuclear architecture is also observed in nuclear envelopathies and laminopathies-HGPS a typical example with aggregation or absence of nuclear lamina proteins or NPC (Goldman et al., 2004) . For DNA export, we postulate three options: NPC export, nuclear egress, and nuclear rupture. First, our data with leptomycin blocking nuclear export show that at least in part this nuclear export pathway overlaps with the DNA export pathway. Second, an endogenous egress pathway, which overcomes the NPC size limit, used in nuclear budding by DNA viruses is now reported for nuclear export of large ribonucleoproteins (Speese et al., 2012) . Third, in situations of defective or severely incomplete nuclear perimeter, transient nonlethal nuclear envelope ruptures can take place in several contexts, including cancer cells, laminopathies, migrating cells, and micronuclei (De Vos et al., 2011; Hatch, Fischer, Deerinck, & Hetzer, 2013; Raab et al., 2016; Vargas, Hatch, Anderson, & Hetzer, 2012) , which could allow simple diffusion of DNA to the cytosol. is sequence-independent, though a cGAS recognition motif has been identified (Herzner et al., 2015) . We also do not know if activation of the pathway is proportional to the quantity of DNA accumulated -basal versus induced levels of cytokines in old cells are 2-to 4-fold vs 4-to 10-fold in AT and PS cells. Interactions of DNA sensing with other processes, such as autophagic and lysosomal degradation, are also possible, for example cGAS can interact with Beclin-1 to halt excessive immune activation (Liang et al., 2014) . Furthermore, DNA sensors and regulators are not static within the cell. cGAS localizes to the site of damaged DNA, for example nucleus during mitosis (Yang et al., 2017) and cytosol after damage (Glück et al., 2017) .
STING remains largely cytosolic upon DNA stimulation, but is also found in the ER, Golgi, nuclear membrane, autophagic vesicles, and exosomes. Another DNA sensor IFI16, also upregulated in old cells and AT cells (Duan et al., 2011) , translocates between nucleus and cytosol and interacts with cGAS (Almine et al., 2017) or the AIM2
inflammasome (Kerur et al., 2011) . We expect many more layers of sensing and regulation to link DNA damage with senescence and aging.
A final gap in our knowledge is how DNA-induced inflammation contributes to the phenotypes of aging. IFNI signaling is important in oncogene-induced senescence (Katlinskaya et al., 2016) , aging model of Terc mice (Yu et al., 2015) , and aged human and mouse brains (Baruch et al., 2014) . However, our results in old cells reveal not only upregulated but also downregulated type I IFN-regulated DEGs.
The aging inflammatory signature may thus turn out to be more In vitro replicative senescence serves as a simplified model here.
A limitation is that we observe heterogeneity in inflammatory signatures across three established cell lines, likely due to intrinsic (e.g., genetic) and extrinsic (passage number, culture conditions) variability.
For example, whereas loss of cGAS is reported to reduce a few particular SASP factors (IL-6, IL-8, TNF-α) in three recent studies (Dou et al., 2017; Glück et al., 2017; Yang et al., 2017) , we saw variable responses of 10 detectable factors in old cells when knocking down STING ( Figure S2I ). This variability highlights the need to study many more healthy and disease primary cells before generalizing the findings or extrapolating to human organismal aging. Enhancing degrada- also unable to revive cell-cycle arrest in Ras-induced senescence by ectopic DNASE2 or TREX1 (Takahashi et al., 2018) . These suggest technical hurdles in removing excess DNA sufficiently or the existence of other factors that induce or maintain senescence.
If self-DNA contributes to aging-associated inflammation and cellular senescence, then modulating any step in the process we elucidated (i.e., DNA damage, transport, sensing and degradation) may be therapeutically useful. Beyond conventional anti-inflammatory drugs (such as aspirin and NSAIDs), we propose that reducing DNA in the LAN ET AL.
| 9 of 12 cytosolic environment could reduce inflammation and act as a novel therapeutic strategy for treating degenerative and aging-associated diseases, especially laminopathies with nuclear DNA found in the cytosol, and interferonopathies caused by loss of degradation components (Rodero et al., 2017 
| DNASE2A overexpression
Human DNASE2A ORF or control eGFP was cloned into a constitutive pLX304 vector with blasticidin resistance (Genetic Perturbation Platform, Broad Institute). Plasmid DNA was purified and transfected into 293 cells for packaging of lentiviruses, and viruses produced were used to infect human fibroblasts. Blasticidin selection was at 10 μg/ml, 24-48 hr.
Additional details for Experimental Procedures are supplied in
Supporting Information Appendix S1.
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